Filing Flows › Sotera Health (SHC) › Q2 2026
Sotera Health (SHC) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 6, 2026
Sotera Health (SHC) reported revenue of $321M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +15% from the quarter before. Operating margin was 24.3%, net earnings $53.6M (16.7% of revenue).
Sotera Health, Q2 2026: revenue $321M (+9% year over year), operating margin 24.3%, net earnings $53.6M, operating cash flow $88.5M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $321M | +15% | +9% |
| Gross profit | $178M | +21% | +7% |
| Operating profit | $78.1M | +83% | +313% |
| Net earnings | $53.6M | +102% | +574% |
| Operating cash flow | $88.5M | +201% | +54% |
| Free cash flow | $42.0M | — | +61% |
What changed
Revenue was $321.4M in Q2 2026, up 9% year over year and up 15% from the previous quarter. Sterigenics was the largest line at 66% of revenue. Sterigenics added $16.7M year over year (up 9%), 62% of the total change.
Gross margin was 55.4%, down 1.2 points from Q2 2025. Operating profit was $78.1M, a 24.3% margin (up 17.9 points year over year). Of the extra revenue versus Q2 2025, 219% reached operating profit, above the 6% margin then. Operating expenses fell 32% while revenue rose 9%. Net earnings were $53.6M, up 574% year over year. The effective tax rate was 31.3%.
Operating cash flow was $88.5M (up 54% year over year), 165% of net earnings. Non-cash charges added back $33.4M of depreciation and amortization and $7.2M of share-based compensation. Working capital and other items used $5.8M. Capital expenditures of $46.4M left free cash flow of $42.0M.
Questions
What was Sotera Health's revenue in the second quarter 2026?
Sotera Health (SHC) reported revenue of $321M for the second quarter 2026 (Q2 2026), +9% from a year earlier and +15% from the quarter before.
Was Sotera Health profitable in the second quarter 2026?
Operating profit was $78.1M (24.3% of revenue) and net earnings $53.6M.
Source: Sotera Health 10-Q on SEC EDGAR.